Latest Pulmonary embolism Stories
While the surveyed physicians were pleased that new blood thinning options such as Xarelto are now available, there was concern about the lack of an antidote to reverse internal bleeding, a side
SAN ANTONIO, Feb. 19, 2015 /PRNewswire/ -- Enrollment for The Angel Catheter® Clinical Trial has begun with three patients successfully enrolled.
Guidelines Poised to Change Standard of Care for Stroke Treatment and Help Caregivers Lower Incidences of Venous Thromboembolism (VTE) in Ischemic and Hemorrhagic Stroke Patients NASHVILLE,
TOKYO and PARSIPPANY, N.J., Feb.
The Firm is representing a number of Xarelto lawsuit plaintiffs who allegedly experienced dangerous internal bleeding and other complications related to their use of the blood thinner.
Multimedia Living with VTE Campaign Includes Pocket Film WASHINGTON, Jan.
The revelations come amid a growing number of Xarelto lawsuits that, among other things, question the marketing tactics used to drive sales of the blood thinner. New
SAN ANTONIO, Jan. 8, 2015 /PR Newswire/ -- BiO(2) Medical announces approval of an IDE to initiate a clinical investigation of the Angel® Catheter for Pulmonary Embolism (PE) protection.
- Withering but not falling off, as a blossom that persists on a twig after flowering.